Invention Grant
- Patent Title: Crystalline pharmaceutically active ingredients
- Patent Title (中): 结晶药物活性成分
-
Application No.: US13885509Application Date: 2011-11-16
-
Publication No.: US09321733B2Publication Date: 2016-04-26
- Inventor: Imre Markovits , Ferenc Jurak , Gyorgyi Kovanyine Lax , Csaba Hamori , Balazs Havasi , Eva Sipos , Balazs Volk , Zsolt Runge , Krisztina Fodorne Kocsmar , Gyula Lukacs , Katalin Kataine Fadgyas , Monika Mezovari
- Applicant: Imre Markovits , Ferenc Jurak , Gyorgyi Kovanyine Lax , Csaba Hamori , Balazs Havasi , Eva Sipos , Balazs Volk , Zsolt Runge , Krisztina Fodorne Kocsmar , Gyula Lukacs , Katalin Kataine Fadgyas , Monika Mezovari
- Applicant Address: HU Budapest
- Assignee: EGIS Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag
- Current Assignee: EGIS Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag
- Current Assignee Address: HU Budapest
- Agency: Millen White Zelano and Branigan, PC
- Agent Csaba Henter; Anthony Zelano
- Priority: HU1000616 20101116
- International Application: PCT/HU2011/000107 WO 20111116
- International Announcement: WO2012/066365 WO 20120524
- Main IPC: A61K31/505
- IPC: A61K31/505 ; C07D239/02 ; C07D239/42
Abstract:
The present invention is related to crystalline forms of rosuvastatin zinc (2:1) salt. The polymorphs are suitable for use as pharmaceutically active ingredients in the treatment of the diseases of the lipid metabolism including hypercholesterolemia, hyperlipidemia, dyslipidemia or atherosclerosis.
Public/Granted literature
- US20130296353A1 CRYSTALLINE PHARMACEUTICALLY ACTIVE INGREDIENTS Public/Granted day:2013-11-07
Information query
